Literature DB >> 20578970

DNA sequencing errors in molecular diagnostics of filamin myopathy.

Zagaa Odgerel1, Peter F M van der Ven, Dieter O Fürst, Lev G Goldfarb.   

Abstract

BACKGROUND: Filamin myopathy is a neuromuscular disorder manifesting with predominantly limb-girdle muscle weakness and in many patients with diaphragm paralysis and cardiomyopathy, caused by mutations in the filamin C (FLNC) gene. Molecular diagnosis of filamin myopathy based on direct DNA sequencing of coding exons is compromised by the presence of a high homology pseudogene (pseFLNC) located approximately 53.6 kb downstream of the functional FLNC gene on chromosome 7q.
METHODS: Molecular cloning, RT-PCR and real-time PCR methods were used to detect sequence differences between the FLNC and pseFLNC that are implicated in known or potential molecular diagnostic errors. Overall, 50 patients with a phenotype resembling filamin myopathy have been screened for mutations in FLNC.
RESULTS: FLNC sequence inconsistencies caused by the interference from pseFLNC were identified and diagnostic errors involving, in particular, the detection of the most frequent disease-causing FLNC p.W2710X mutation resolved. Mismatches between the FLNC and pseFLNC sequences were tabulated for future use.
CONCLUSIONS: We devise a strategy that allows one to discern mutations occurring in the functional FLNC from those harbored in pseFLNC, thus preventing possible complications in future research and patient genetic testing.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20578970     DOI: 10.1515/CCLM.2010.272

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  6 in total

1.  Novel FLNC mutation in a patient with myofibrillar myopathy in combination with late-onset cerebellar ataxia.

Authors:  Giorgio Tasca; Zagaa Odgerel; Mauro Monforte; Stefania Aurino; Nigel F Clarke; Leigh B Waddell; Bjarne Udd; Enzo Ricci; Lev G Goldfarb
Journal:  Muscle Nerve       Date:  2012-08       Impact factor: 3.217

2.  Filamin C-related myopathies: pathology and mechanisms.

Authors:  Dieter O Fürst; Lev G Goldfarb; Rudolf A Kley; Matthias Vorgerd; Montse Olivé; Peter F M van der Ven
Journal:  Acta Neuropathol       Date:  2012-10-30       Impact factor: 17.088

3.  Pathophysiology of protein aggregation and extended phenotyping in filaminopathy.

Authors:  Rudolf A Kley; Piraye Serdaroglu-Oflazer; Yvonne Leber; Zagaa Odgerel; Peter F M van der Ven; Montse Olivé; Isidro Ferrer; Adekunle Onipe; Mariya Mihaylov; Juan M Bilbao; Hee S Lee; Jörg Höhfeld; Kristina Djinović-Carugo; Kester Kong; Martin Tegenthoff; Sören A Peters; Werner Stenzel; Matthias Vorgerd; Lev G Goldfarb; Dieter O Fürst
Journal:  Brain       Date:  2012-09       Impact factor: 13.501

4.  FLNC-Associated Myofibrillar Myopathy: New Clinical, Functional, and Proteomic Data.

Authors:  Rudolf Andre Kley; Yvonne Leber; Bertold Schrank; Heidi Zhuge; Zacharias Orfanos; Julius Kostan; Adekunle Onipe; Dominik Sellung; Anne Katrin Güttsches; Britta Eggers; Frank Jacobsen; Wolfram Kress; Katrin Marcus; Kristina Djinovic-Carugo; Peter F M van der Ven; Dieter O Fürst; Matthias Vorgerd
Journal:  Neurol Genet       Date:  2021-05-18

5.  Exome analysis of two limb-girdle muscular dystrophy families: mutations identified and challenges encountered.

Authors:  Kristin K McDonald; Jeffrey Stajich; Colette Blach; Allison E Ashley-Koch; Michael A Hauser
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

6.  Investigating the role of filamin C in Belgian patients with frontotemporal dementia linked to GRN deficiency in FTLD-TDP brains.

Authors:  Jonathan Janssens; Stéphanie Philtjens; Gernot Kleinberger; Sara Van Mossevelde; Julie van der Zee; Rita Cacace; Sebastiaan Engelborghs; Anne Sieben; Julia Banzhaf-Strathmann; Lubina Dillen; Céline Merlin; Ivy Cuijt; Caroline Robberecht; Bettina Schmid; Patrick Santens; Adrian Ivanoiu; Mathieu Vandenbulcke; Rik Vandenberghe; Patrick Cras; Peter P De Deyn; Jean-Jacques Martin; Stuart Maudsley; Christian Haass; Marc Cruts; Christine Van Broeckhoven
Journal:  Acta Neuropathol Commun       Date:  2015-11-10       Impact factor: 7.801

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.